Your Position:Products>Monoclonals/Polyclonals

Anti-Human IL-13 Reference Antibody

货号:RB9THW632016
  • Price:Negotiable
  • Click:141

Product Detail

Product Details

FormLiquid
Host SpeciesHumanized
ClonalityMonoclonal
IsotypeIgG1-kappa
Purity>95% as determined by SDS-PAGE.
PurificationProtein A/G purified from cell culture supernatant.
Concentration5.25 mg/ml
Endotoxin LevelPlease contact with the lab for this information.
ApplicationsELISA, Bioactivity: FACS, Functional assay, Research in vivo
Species ReactivityHuman
TargetIL13, NC30, Interleukin-13, IL-13
Storage Buffer0.01M PBS, pH 7.4.
Stability and StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Expression SystemMammalian Cells
Accession NumberP35225
BackgroundCendakimab (RPC4046; ABT 308; CC-93538) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both IL-13Rα1 and IL-13Rα2 with IC50s of 352 pM and 631 pM by ELISA, respectively. Cendakimab recognizes both wild-type human IL-13 and the common polymorphic variant R110Q, with binding affinities of 52 and 50 pM, respectively. Cendakimab has the potential for IL-13-related allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis).<br>
Alternative Names13C5.5, ABT-308, RPC-4046, 2151032-62-9
SpeciesHuman
NoteFor research use only. Not suitable for clinical or therapeutic use.